Polycystic Ovary Syndrome (PCOS) Protocol

Women's HealthStrong Evidence

supplements

Primary

Supporting

Grade A

120

Studies

Primary Stack

Core supplements with strongest evidence

Inositol (Myo-inositol + D-chiro-inositol)A

2-4g myo-inositol + 50-100mg D-chiro-inositol daily (40:1 ratio)

Acts as insulin signaling second messenger, improving insulin sensitivity, restoring ovulation, and reducing androgens

↓Blood glucose↓Acne Symptoms↑Testosterone↓PCOS Symptoms↓Body Mass Index (BMI)

40 studies3,000 participants

Supporting Studies (3)

PMID: 22774396 - Myo-inositol for PCOS: meta-analysis (2012)PMID: 28526477 - Combined myo-inositol and D-chiro-inositol for PCOS (2017)PMID: 26774657 - Inositol for ovulation induction in PCOS: systematic review (2016)

BerberineA

500mg 2-3x daily with meals

Activates AMPK to improve insulin sensitivity, reduces androgens, and regulates menstrual cycles comparable to metformin

↓Apolipoprotein B↓Triglycerides↓Low-density lipoprotein (LDL)↑High-density lipoprotein (HDL)↓Total cholesterol

15 studies1,200 participants

Supporting Studies (2)

PMID: 22129249 - Berberine vs metformin for PCOS: RCT (2012)PMID: 31423490 - Berberine for PCOS: meta-analysis (2019)

Supporting Stack

Additional supplements for enhanced results

N-Acetylcysteine (NAC)B

600-1800mg daily

Antioxidant that improves insulin sensitivity, reduces androgens, and enhances ovulation rates

↓Blood glucose↓Body Mass Index (BMI)↑Endometrial Thickness↑Estrogen↑Luteinizing Hormone

15 studies1,000 participants

Supporting Studies (1)

PMID: 25078573 - NAC for PCOS: systematic review and meta-analysis (2014)

Vitamin DB

2000-4000 IU daily (target 40-60 ng/mL)

Deficiency is prevalent in PCOS; supplementation improves insulin sensitivity, menstrual regularity, and fertility

↓Blood glucose↑High-density lipoprotein (HDL)↑Insulin↓Low-density lipoprotein (LDL)↓Total cholesterol

20 studies1,500 participants

Supporting Studies (1)

PMID: 28395348 - Vitamin D for PCOS: meta-analysis (2017)

Omega-3 Fatty AcidsB

2-4g EPA/DHA daily

Reduces inflammation, improves lipid profile, and may reduce androgen levels in PCOS

Adiponectin↑Glycemic Control↓Blood glucose↓C-Reactive Protein (CRP)↓HbA1c

12 studies600 participants

Supporting Studies (1)

PMID: 29387251 - Omega-3 for PCOS: systematic review (2018)

ChromiumB

200-1000mcg daily (as chromium picolinate)

Enhances insulin receptor sensitivity, potentially improving metabolic and reproductive parameters

↓Acne Symptoms↑Glutathione (GSH)↓C-Reactive Protein (CRP)↑Total Antioxidant Capacity (TAC)↑Free Testosterone

10 studies500 participants

Supporting Studies (1)

PMID: 28353401 - Chromium supplementation for PCOS: meta-analysis (2017)

Coenzyme Q10B

100-200mg daily

Antioxidant that may improve glucose metabolism, blood pressure, and cholesterol in PCOS

↓Blood glucose↑Testosterone↑Progesterone↓Insulin Resistance↑Luteinizing Hormone

8 studies400 participants

Supporting Studies (1)

PMID: 27712817 - CoQ10 for metabolic profiles in PCOS: RCT (2017)

How This Protocol Works

Simple Explanation

Polycystic ovary syndrome (PCOS) is the most common hormonal disorder in women of reproductive age, affecting 6-12% of women. It's characterized by irregular periods, excess androgen ('male hormones'), and polycystic ovaries. The underlying problem is usually insulin resistance—when your cells don't respond well to insulin, your pancreas produces more, and high insulin stimulates the ovaries to make more testosterone. This protocol targets insulin resistance and its downstream hormonal effects.

•Inositol is the most evidence-based supplement for PCOS. Myo-inositol and D-chiro-inositol are naturally occurring compounds that act as 'second messengers' in insulin signaling—they help insulin work more effectively. Studies show inositol can restore ovulation, lower testosterone, improve egg quality, and reduce acne and hirsutism. The combination of myo-inositol and D-chiro-inositol in a 40:1 ratio (mimicking the body's natural ratio) appears most effective.

•Berberine is remarkably effective for PCOS—head-to-head studies show it works as well as metformin (the most commonly prescribed PCOS medication) for improving insulin sensitivity and reducing androgens. It activates AMPK, the same pathway targeted by metformin. Berberine can regulate menstrual cycles, reduce testosterone, and improve metabolic markers. Some women tolerate it better than metformin.

•N-Acetylcysteine (NAC) is a powerful antioxidant that increases glutathione, your body's master antioxidant. In PCOS, oxidative stress contributes to insulin resistance and ovarian dysfunction. NAC improves insulin sensitivity, reduces androgen levels, and may enhance ovulation rates. It's been studied as an alternative to metformin with comparable results in some trials.

•Vitamin D deficiency is extremely common in PCOS (67-85% of women) and correlates with worse insulin resistance and metabolic profiles. Supplementation can improve insulin sensitivity, reduce inflammation, and may improve menstrual regularity and fertility. Get your levels tested and aim for 40-60 ng/mL.

•Omega-3 Fatty Acids reduce the chronic low-grade inflammation seen in PCOS and improve lipid profiles. They may also have modest effects on reducing androgens and improving insulin sensitivity.

•Chromium enhances insulin receptor function, and some studies show it can improve glucose tolerance and reduce testosterone in PCOS. Effects are modest but may complement other interventions.

•Coenzyme Q10 is an antioxidant that may improve various metabolic parameters in PCOS, including glucose metabolism and lipid profiles.

Expected timeline: Metabolic improvements (fasting glucose, insulin) may be seen in 4-8 weeks. Menstrual regularity often improves within 2-3 cycles (2-3 months). Improvements in acne and hirsutism take longer (3-6 months). Weight loss and lifestyle changes enhance all supplement effects.

Clinical Perspective

PCOS is diagnosed by the Rotterdam criteria (2 of 3: oligo/anovulation, clinical/biochemical hyperandrogenism, polycystic ovaries on ultrasound). Central pathophysiology involves insulin resistance and compensatory hyperinsulinemia, which stimulates ovarian thecal cell androgen production and inhibits hepatic SHBG synthesis. This creates a cycle of hyperandrogenism, anovulation, and metabolic dysfunction. Long-term risks include T2DM, cardiovascular disease, endometrial cancer, and infertility. This protocol targets insulin sensitization, androgen reduction, and metabolic optimization.

•Inositol (A-grade): Myo-inositol (MI) and D-chiro-inositol (DCI) are insulin-sensitizing secondary messengers. MI converts to DCI via epimerase; PCOS patients have reduced conversion. MI works primarily in ovaries (FSH signaling), DCI in peripheral tissues (insulin signaling). Meta-analysis: MI restores ovulation (OR 2.3), reduces testosterone, improves oocyte quality (PMID: 22774396). Combined MI+DCI in 40:1 ratio superior to either alone for metabolic and reproductive outcomes (PMID: 28526477). Dose: 2-4g MI + 50-100mg DCI daily.

•Berberine (A-grade): Activates AMPK, the same target as metformin. Increases glucose uptake via GLUT4 translocation, inhibits hepatic gluconeogenesis, reduces lipogenesis. Head-to-head RCT vs metformin: similar improvements in insulin sensitivity, reduction in testosterone, improvement in LH:FSH ratio, and menstrual regularity (PMID: 22129249). Meta-analysis confirms efficacy comparable to metformin with potentially better lipid effects (PMID: 31423490). Dose: 1500mg/day divided with meals. GI side effects similar to metformin.

•N-Acetylcysteine (B-grade): Cysteine prodrug that replenishes glutathione, major intracellular antioxidant. Oxidative stress contributes to PCOS pathophysiology (increased ROS, decreased antioxidants). NAC also directly improves insulin receptor signaling. Systematic review: improves insulin sensitivity, reduces testosterone and LH, enhances ovulation rate (PMID: 25078573). Some trials show similar efficacy to metformin for ovulation induction. Dose: 1200-1800mg/day.

•Vitamin D (B-grade): VDR expressed in ovaries, endometrium, and granulosa cells. Deficiency (67-85% of PCOS) associated with worse insulin resistance, higher androgens, and reduced fertility. Meta-analysis: supplementation improves HOMA-IR, fasting glucose, lipids, and may improve menstrual regularity (PMID: 28395348). Check 25(OH)D levels; supplement to achieve 40-60 ng/mL. Dose: 2000-4000 IU/day based on levels.

•Omega-3 Fatty Acids (B-grade): EPA/DHA reduce inflammation (lower hsCRP, IL-6), improve lipid profile (reduce TG, increase HDL), and may reduce androgens via decreased 5α-reductase activity. Systematic review: improvements in insulin resistance, lipids, with some evidence for androgen reduction (PMID: 29387251). Dose: 2-4g EPA+DHA daily.

•Chromium (B-grade): Essential trace mineral that enhances insulin receptor signaling. May improve insulin sensitivity and glucose tolerance in PCOS. Meta-analysis: modest improvements in BMI, fasting insulin, free testosterone (PMID: 28353401). Effects may be more pronounced in those with higher baseline insulin resistance. Dose: 200-1000mcg chromium picolinate daily.

•Coenzyme Q10 (B-grade): Lipophilic antioxidant in mitochondrial electron transport chain. May improve mitochondrial function and reduce oxidative stress. RCT: 100mg/day for 12 weeks improved fasting glucose, insulin, HOMA-IR, and lipids in PCOS (PMID: 27712817). Also may improve oocyte quality.

Biomarker targets: Fasting glucose/insulin, HOMA-IR, HbA1c, LH:FSH ratio (target <2), total/free testosterone, SHBG, DHEA-S, lipid panel, 25(OH)D, menstrual regularity, ovulation tracking (BBT, LH testing).

Protocol notes: Lifestyle modification is foundational—5-10% weight loss significantly improves metabolic and reproductive outcomes. Low glycemic index diet reduces insulin spikes. Exercise (both aerobic and resistance) improves insulin sensitivity independent of weight loss. Metformin remains first-line pharmacotherapy; berberine and inositol are evidence-based alternatives. Anti-androgens (spironolactone) for hirsutism/acne if supplements insufficient. Fertility: inositol may be combined with clomiphene. Monitor liver function with berberine. Address mental health—PCOS associated with increased anxiety and depression. Long-term: screen for T2DM (OGTT), endometrial health (consider progesterone withdrawal if prolonged amenorrhea), cardiovascular risk factors.

View All Protocols